CN Patent

CN107249615B — 潮热抑制剂

Assigned to Meiji Co Ltd · Expires 2021-02-05 · 5y expired

What this patent protects

本发明涉及一种含有α‑乳白蛋白作为有效成分的潮热抑制剂和更年期障碍改善剂、以及用于抑制潮热的饮食品和药物。

USPTO Abstract

本发明涉及一种含有α‑乳白蛋白作为有效成分的潮热抑制剂和更年期障碍改善剂、以及用于抑制潮热的饮食品和药物。

Drugs covered by this patent

paroxetine-mesylate (PAROXETINE MESYLATE)

Patent Metadata

Patent number: CN107249615B
Jurisdiction: CN
Classification: —
Expires: 2021-02-05
Drug substance claim: No
Drug product claim: No
Assignee: Meiji Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.